; Seegene, Inc. - Product Pipeline Analysis
Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out
Your Federal Quarterly Tax Payments are due April 15th Get Help Now >>

Seegene, Inc. - Product Pipeline Analysis

VIEWS: 81 PAGES: 58

Seegene, Inc. - Product Pipeline Analysis Summary This report is a source for data, analysis and actionable intelligence on the Seegene, Inc. portfolio of pipeline products. The report provides detailed analysis on each pipeline product with information on the indication, the development stage, trial phase, product milestones, pipeline territory, estimated approval date, and estimated launch date. Each pipeline product is profiled to cover information on product description, function, technology, indication, and application. The report is also supplemented with a detailed company profile and information on clinical trials, wherever applicable. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s team of industry experts. Scope - Detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments. - Detailed coverage on all the pipeline products, by equipment type, by therapy area, by development stage, and by trial phase. - Information on product milestones and pipeline territory for each product, the estimated approval date, and estimated launch date. - Profile of each pipeline product with additional information on product description, function, technology, indication(s), and application. - Data on relevant clinical trials and product patent details, wherever applicable. - Information on clinical trial, wherever applicable, is supplemented with information on trial phase, trial status, trial objective, trial design, target patients, unique physician identifier, primary point, secondary point, acronym, participants inclusion, participants exclusion, interventions, trial results, trial start date, trial end date, study type, trial site, trial funding, age eligibility, and gender eligibility. Reasons to Buy - Dev

More Info
  • pg 1
									                                                 Seegene, Inc. - Product Pipeline Analysis
     Reference Code: GDME23818PD                                                                                                  Publication Date: NOV 2010



     Company Snapshot                                                         Company Overview
     Key Information
                                                                              Seegene, Inc. (Seegene) is engaged the design, development and
      Seegene, Inc., Key Facts                                                marketing of molecular diagnostic tools. It specializes in oligo technologies.
                                                                              The product portfolio of the company includes molecular Diagnostics Tests
      Web Address                           www.seegene.com
                                                                              and reagents for pathogen detection. In addition to this the company
      Industry                              Pharmaceuticals and Healthcare-   provides genome diagnostic kits for research purposes. It has research and
      Source:Primary / Secondary Research                                     development wing concentrates on developing new technologies and
      GlobalData                                                              products to the healthcare markets. The company is an ISO 9001:2000 and
                                                                              ISO 13485:2003 certified company and is CE approved for its sale in the
                                                                              European market. It has a subsidiary in the US and markets its products
                                                                              through its distributors located globally.



     Seegene, Inc. Pipeline Products

      Seegene, Inc. Key Pipeline Products by Equipment                        Seegene, Inc. Key Pipeline Products by Therapy Area
      Type
     Equipment Type                           No of Products                  Therapy Area                                                 No of Products
     Infectious Immunology                               43                   Sexually transmitted diseases                                            6
     Genetic Testing                                      9                   Respiratory Infection                                                       5
                                                                              Tuberculosis                                                                5
                                                                              Human papillomavirus infection                                              3
                                                                              Influenza                                                                   3
                                                                              Influenza A H1N1 viral infection                                            3
                                                                              Vancomycin-resistant enterococci infections                                 3
     Source: Primary / Secondary Research                                     Source: Primary / Secondary Research
     GlobalData                                                               GlobalData


     Seegene, Inc. Key Pipeline Products by Equipment Type




      Source: Primary / Secondary Research
      GlobalData




     Seegene, Inc. Key Pipeline Products by Development                       Seegene, Inc. Key Pipeline Products by Trial Phase
     Stage
     Developmental Stage                     No of Products                   Trial Phase                                                  No of Products
     Clinicals                                          50                    Phase IV                                                 -
     Pre-Clinicals                                                            Phase III                                                -
                                              -
     Early development                                                        Phase II                                                 -
                                                              -
     No Specific Phase                                                    1   Phase I                                                  -
     Source: Primary / Secondary Research                                     Source: Primary / Secondary Research
     GlobalData                                                               GlobalData
     Note : (-) indicates 'Not Available'                                     Note : (-) indicates 'Not Available'




Seegene, Inc. - Product Pipeline Analysis                                                                                            Reference Code: GDME23818PD

Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
     Table of Contents
     Table of Contents................................................................................................................................................................................................................................................................... 2
     List of Tables .......................................................................................................................................................................................................................................................................... 5
     List of Figures......................................................................................................................................................................................................................................................................... 8
     Key Facts ............................................................................................................................................................................................................................................................................... 9
     Seegene, Inc. - Major Products and Services...................................................................................................................................................................................................................... 10
           Seegene, Inc. Pipeline Products by Equipment Type.................................................................................................................................................................................................... 11
           Seegene, Inc. Pipeline Products by Development Stage .............................................................................................................................................................................................. 14
           Seegene, Inc. Pipeline Products by Therapy Area ........................................................................................................................................................................................................ 17
           Seegene, Inc. Pipeline Products by Trial Phase............................................................................................................................................................................................................ 19
           Seegene, Inc. Pipeline Products by Milestone Summary .............................................................................................................................................................................................. 21
           Anyplex CT/NG Real-time Detection Assay .................................................................................................................................................................................................................. 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
           Anyplex FluA 2 Real-time Subtyping Assay .................................................................................................................................................................................................................. 23
                 Product Status......................................................................................................................................................................................................................................................... 23
                 Product Description ................................................................................................................................................................................................................................................. 23
           Anyplex FluA 3 Real-time Subtyping Assay .................................................................................................................................................................................................................. 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 24
           Anyplex FluA/New H1N1 Real-time Detection Assay.................................................................................................................................................................................................... 24
                 Product Status......................................................................................................................................................................................................................................................... 24
                 Product Description ................................................................................................................................................................................................................................................. 24
           Anyplex MDR-TB Screening Test.................................................................................................................................................................................................................................. 25
                 Product Status......................................................................................................................................................................................................................................................... 25
                 Product Description ................................................................................................................................................................................................................................................. 25
                 Product Milestone ................................................................................................................................................................................................................................................... 25
           Anyplex MTB/NTM Real-Time Detection Assay ............................................................................................................................................................................................................ 26
                 Product Status......................................................................................................................................................................................................................................................... 26
                 Product Description ................................................................................................................................................................................................................................................. 26
           Anyplex VanR Real-time Detection ............................................................................................................................................................................................................................... 26
                 Product Status......................................................................................................................................................................................................................................................... 26
                 Product Description ................................................................................................................................................................................................................................................. 26
           Leukemia PML/RARa Assay ......................................................................................................................................................................................................................................... 27
                 Product Status......................................................................................................................................................................................................................................................... 27
                 Product Description ................................................................................................................................................................................................................................................. 27
           Magicplex FluA 4 Real-time Subtyping Assay ............................................................................................................................................................................................................... 27
                 Product Status......................................................................................................................................................................................................................................................... 27
                 Product Description ................................................................................................................................................................................................................................................. 27
           Magicplex Hepa Trio Real-Time Test ............................................................................................................................................................................................................................ 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 28
           Magicplex HPV 16/18 Real-time Test............................................................................................................................................................................................................................ 28
                 Product Status......................................................................................................................................................................................................................................................... 28
                 Product Description ................................................................................................................................................................................................................................................. 28
           Magicplex HSV 1/2 Real-time Test................................................................................................................................................................................................................................ 29
                 Product Status......................................................................................................................................................................................................................................................... 29
                 Product Description ................................................................................................................................................................................................................................................. 29
           Magicplex MTB Real-time Test...................................................................................................................................................................................................................................... 29
                 Product Status......................................................................................................................................................................................................................................................... 29
                 Product Description ................................................................................................................................................................................................................................................. 29
           Magicplex STI1 Real-time Test...................................................................................................................................................................................................................................... 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
           Magicplex VanR Real-time Test .................................................................................................................................................................................................................................... 30
                 Product Status......................................................................................................................................................................................................................................................... 30
                 Product Description ................................................................................................................................................................................................................................................. 30
           Seeplex 18-Plex Respiratory Test ................................................................................................................................................................................................................................. 31
                 Product Status......................................................................................................................................................................................................................................................... 31
                 Product Description ................................................................................................................................................................................................................................................. 31
                 Product Milestone ................................................................................................................................................................................................................................................... 31

Seegene, Inc. - Product Pipeline Analysis                                                                                                                                                                                                            Reference Code: GDME23818PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                                     Page 2
         Seeplex ApoE Genotyping Assay.................................................................................................................................................................................................................................. 32
              Product Status......................................................................................................................................................................................................................................................... 32
              Product Description ................................................................................................................................................................................................................................................. 32
         Seeplex BRAF V600E ACE Detection Assay ................................................................................................................................................................................................................ 32
              Product Status......................................................................................................................................................................................................................................................... 32
              Product Description ................................................................................................................................................................................................................................................. 32
         Seeplex Candida Detection Assay ................................................................................................................................................................................................................................ 33
              Product Status......................................................................................................................................................................................................................................................... 33
              Product Description ................................................................................................................................................................................................................................................. 33
         Seeplex ClaR-H.pylori ACE Detection Assay ................................................................................................................................................................................................................ 33
              Product Status......................................................................................................................................................................................................................................................... 33
              Product Description ................................................................................................................................................................................................................................................. 33
         Seeplex CYP2C19 ACE Genotyping Assay .................................................................................................................................................................................................................. 33
              Product Status......................................................................................................................................................................................................................................................... 34
              Product Description ................................................................................................................................................................................................................................................. 34
         Seeplex Diarrhea ACE Detection Assay........................................................................................................................................................................................................................ 34
              Product Status......................................................................................................................................................................................................................................................... 34
              Product Description ................................................................................................................................................................................................................................................. 34
              Product Milestone ................................................................................................................................................................................................................................................... 34
         Seeplex FluA ACE Subtyping Test ................................................................................................................................................................................................................................ 35
              Product Status......................................................................................................................................................................................................................................................... 35
              Product Description ................................................................................................................................................................................................................................................. 35
              Product Milestone ................................................................................................................................................................................................................................................... 35
         Seeplex GBS-R ACE Detection Assay .......................................................................................................................................................................................................................... 36
              Product Status......................................................................................................................................................................................................................................................... 36
              Product Description ................................................................................................................................................................................................................................................. 36
         Seeplex HBV Lami-resistant ACE ................................................................................................................................................................................................................................. 36
              Product Status......................................................................................................................................................................................................................................................... 36
              Product Description ................................................................................................................................................................................................................................................. 36
         Seeplex HPV/STD4 ACE Screening.............................................................................................................................................................................................................................. 37
              Product Status......................................................................................................................................................................................................................................................... 37
              Product Description ................................................................................................................................................................................................................................................. 37
         Seeplex HPV4 ACE Screening...................................................................................................................................................................................................................................... 37
              Product Status......................................................................................................................................................................................................................................................... 37
              Product Description ................................................................................................................................................................................................................................................. 37
         Seeplex HPV4A ACE Screening Assay......................................................................................................................................................................................................................... 38
              Product Status......................................................................................................................................................................................................................................................... 38
              Product Description ................................................................................................................................................................................................................................................. 38
         Seeplex HSV2 ACE Detection Assay ............................................................................................................................................................................................................................ 38
              Product Status......................................................................................................................................................................................................................................................... 38
              Product Description ................................................................................................................................................................................................................................................. 38
         Seeplex Influenza A/B OneStep Typing ........................................................................................................................................................................................................................ 39
              Product Status......................................................................................................................................................................................................................................................... 39
              Product Description ................................................................................................................................................................................................................................................. 39
         Seeplex Leukemia AML1/ETO ACE Assay ................................................................................................................................................................................................................... 39
              Product Status......................................................................................................................................................................................................................................................... 39
              Product Description ................................................................................................................................................................................................................................................. 39
         Seeplex Leukemia BCR/ABL Assay .............................................................................................................................................................................................................................. 40
              Product Status......................................................................................................................................................................................................................................................... 40
              Product Description ................................................................................................................................................................................................................................................. 40
         Seeplex Meningitis ACE Detection Assay ..................................................................................................................................................................................................................... 40
              Product Status......................................................................................................................................................................................................................................................... 40
              Product Description ................................................................................................................................................................................................................................................. 40
              Product Milestone ................................................................................................................................................................................................................................................... 41
         Seeplex MRSA ACE Detection Assay ........................................................................................................................................................................................................................... 41
              Product Status......................................................................................................................................................................................................................................................... 41
              Product Description ................................................................................................................................................................................................................................................. 41
         Seeplex MTB ACE Detection Assay.............................................................................................................................................................................................................................. 41
              Product Status......................................................................................................................................................................................................................................................... 41
              Product Description ................................................................................................................................................................................................................................................. 41
              Product Milestone ................................................................................................................................................................................................................................................... 42
         Seeplex MTB Nested ACE Detection ............................................................................................................................................................................................................................ 42
              Product Status......................................................................................................................................................................................................................................................... 42


Seegene, Inc. - Product Pipeline Analysis                                                                                                                                                                                                    Reference Code: GDME23818PD

Source : www.globalcompanyintelligence.com                                                                                                                                                                                                                                             Page 3
                 Product Description ................................................................................................................................................................................................................................................. 42
           Seeplex MTB/BCG ACE Detection................................................................................................................................................................................................................................ 42
   
								
To top
;